Cargando…
Physiologically based metformin pharmacokinetics model of mice and scale-up to humans for the estimation of concentrations in various tissues
Metformin is the primary drug for type 2 diabetes treatment and a promising candidate for other disease treatment. It has significant deviations between individuals in therapy efficiency and pharmacokinetics, leading to the administration of an unnecessary overdose or an insufficient dose. There is...
Autores principales: | Zake, Darta Maija, Kurlovics, Janis, Zaharenko, Linda, Komasilovs, Vitalijs, Klovins, Janis, Stalidzans, Egils |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026019/ https://www.ncbi.nlm.nih.gov/pubmed/33826656 http://dx.doi.org/10.1371/journal.pone.0249594 |
Ejemplares similares
-
Metformin Transport Rates Between Plasma and Red Blood Cells in Humans
por: Kurlovics, Janis, et al.
Publicado: (2021) -
Model-based metabolism design: constraints for kinetic and stoichiometric models
por: Stalidzans, Egils, et al.
Publicado: (2018) -
Genome Database of the Latvian Population (LGDB): Design, Goals, and Primary Results
por: Rovite, Vita, et al.
Publicado: (2018) -
Association of metformin administration with gut microbiome dysbiosis in healthy volunteers
por: Elbere, Ilze, et al.
Publicado: (2018) -
The Association of Common SNPs and Haplotypes in CETP Gene with HDL Cholesterol Levels in Latvian Population
por: Radovica, Ilze, et al.
Publicado: (2013)